Table 1.
Clinical data of controls and patients with multiple sclerosis included in this study
| Clinical multiple sclerosis type | Age | Gender | Disease course | Total disease duration (months) | Lesion types |
|---|---|---|---|---|---|
| AMS 1 | 45 | Male | Monophasic | 0.2 | Active (Pattern III); inactive |
| AMS 2 | 45 | Male | Monophasic | 0.6 | Active (Pattern III), inactive |
| AMS 3 | 52 | Male | Monophasic | 1.5 | Active (Pattern II), inactive |
| AMS 4 | 35 | Male | Monophasic | 2 | Active (Pattern II; inactive |
| AMS 5 | 78 | Male | Monophasic | 2 | Active (Pattern III); inactive |
| AMS 6 | 34 | Female | Monophasic | 4 | Active (Pattern III); inactive |
| AMS 7 | 51 | Female | Monophasic | 5 | Active (Pattern II), inactive |
| RRMS 1 | 40 | Female | RRMS | 120 | Active (Pattern III); inactive |
| RRMS 2 | 57 | Female | RRMS | 156 | Active (Pattern II); inactive |
| SPMS 1 | 66 | Female | SPMS with attacks | 96 | Inactive |
| SPMS 2 | 34 | Male | SPMS with attacks | >120 | Inactive |
| SPMS 3 | 62 | Female | SPMS without attacks | 144 | Active (Pattern I) |
| SPMS 4 | 84 | Female | SPMS without attacks | 264 | Inactive |
| SPMS 5 | 61 | Female | SPMS with attacks | 288 | Slowly expanding active; inactive |
| SPMS 6 | 64 | Female | SPMS without attacks | 336 | Inactive |
| SPMS 7 | 56 | Male | SPMS without attacks | 372 | Active (Pattern I); inactive |
| SPMS 8 | 76 | Male | SPMS without attacks | 372 | Inactive |
| SPMS 9 | 78 | Female | SPMS without attacks | 372 | Inactive |
| SPMS 10 | 69 | Female | SPMS without attacks | 384 | Inactive |
| SPMS 11 | 81 | Female | SPMS without attacks | 432 | Inactive |
| SPMS 12 | 46 | Female | SPMS with attacks | 444 | Slowly expanding active; inactive |
| PPMS 1 | 55 | Female | PPMS | 60 | Slowly expanding active; inactive |
| PPMS 2 | 67 | Male | PPMS | 87 | Active (Pattern I), inactive |
| PPMS 3 | 53 | Male | PPMS | 168 | Slowly expanding active; inactive |
| PPMS 4 | 77 | Female | PPMS | 168 | Slowly expanding active; inactive |
| PPMS 5 | 34 | Female | PPMS | 204 | Slowly expanding active; inactive |
| PPMS 6 | 71 | Female | PPMS | 264 | Slowly expanding active; inactive |
| PPMS 7 | 83 | Female | PPMS | 360 | Inactive |
| PPMS 8 | 75 | Female | PPMS | 372 | Inactive |
| ProgMS | 68 | Female | Progressive MS | 120 | Inactive |
| NMO | 20 | Female | Relapsing NMO | 48 | Neuromyelitis optica |
| WMS 1 | 85 | Female | Acute stroke | 2 days | Initial white matter stroke lesion |
| WMS 2 | 65 | Female | Recurrent stroke | 48 | Initial and advanced stroke lesions |
| Control 1 | 30 | Female | Normal control | – | – |
| Control 2 | 36 | Female | Normal control | – | – |
| Control 3 | 37 | Male | Normal control | – | – |
| Control 4 | 39 | Female | Normal control | – | – |
| Control 5 | 42 | Female | Normal control | – | – |
| Control 6 | 45 | Female | Normal control | – | – |
| Control 7 | 46 | Male | Normal control | – | – |
| Control 8 | 47 | Female | Normal control | – | – |
| Control 9 | 48 | Male | Normal control | – | – |
| Control 10 | 65 | Male | Normal control | – | – |
| Control 11 | 70 | Male | Normal control | – | – |
| Control 12 | 71 | Female | Normal control | – | – |
| Control 13 | 71 | Female | Normal control | – | – |
| Control 14 | 72 | Male | Normal control | -– | – |
| Control 15 | 83 | Male | Normal control | – | – |
| Control 16 | 84 | Female | Normal control | – | – |
| Control 17 | 97 | Female | Normal control | – | – |
| S-Control | 42 | Female | Septic control | – | – |
| S-Control | 45 | Male | Septic control | – | – |
| S-Control | 51 | Female | Septic control | – | – |
| S-Control | 74 | Male | Septic control | – | – |
| S-Control | 88 | Male | Septic control | – | – |
| S-Control | 89 | Female | Septic control | – | – |
| S-Control | 95 | Female | Septic control | – | – |
AMS = acute multiple sclerosis; MS = multiple sclerosis; NMO = neuromyelitis optica; PPMS = primary progressive multiple sclerosis; RRMS = relapsing/remitting multiple sclerosis; SPMS = secondary progressive multiple sclerosis; WMS = white matter stroke.